Phase II Study of Metastatic Cancer That Overexpresses P53 Using Lymphodepleting Conditioning Followed by Infusion of Anti-P53 TCR-Gene Engineered Lymphocytes

计划入组 12 人 · 首次发布于 2006 年 10 月 26 日

Non-Viral TCR Gene Therapy

首次发布于 2019 年 9 月 25 日

Asthma, Inflammation and G Protein-coupled Receptors (GPCR)

计划入组 205 人 · 首次发布于 2008 年 11 月 19 日

GPCR Trt005

GPCR modulators

JTCR-016

GPCR Therapeutics, Inc.

South Korea

GTC BIOTHERAPEUTICS, INC.

United States

LION TCR PTE. LTD.

Singapore

FTC Challenges $627M GTCR Acquisition of Surmodics Over Market Concentration Concerns

Lion TCR Receives FDA IND Clearance for First-in-Class TCR-T Therapy Targeting Chronic Hepatitis B

GPCR Dimers and Heteromers: Emerging Therapeutic Paradigms in Neuropsychiatric Disorders